Myers Industries Sold More But Kept Less — Can a Q4 Margin Rebound Justify the Stock's Premium?

Shares of Myers Industries cratered as much as 14% on October 29 after the plastics and engineered-products manufacturer reported third-quarter profits that badly missed Wall Street expectations, raising a pointed question: is demand growth worth anything if input costs eat the profits?

• A 76% Resin Spike Ate the Revenue Beat Alive. Revenue of $171.3 million topped the $163.8 million consensus, yet adjusted EPS of $0.32 fell far short of the $0.45 estimate, triggering a roughly 13% stock decline. The culprit was raw-material inflation: polyethylene resin costs surged 76% between March and May , and while Myers raised prices in response, there was a timing lag before those increases could fully offset the spike.

Gross margin — the share of revenue left after production costs — contracted 380 basis points to 27.3%.

• Demand Is Real, But Profits Didn't Follow. Infrastructure revenue soared 38% on composite matting demand, while food-and-beverage sales climbed 12%. Yet adjusted gross profit still fell 4.1% and adjusted operating income dropped 9.9% — a textbook case of a manufacturer growing its top line while surrendering margin to input costs and unplanned maintenance downtime.

• Management's Q4 Margin Promise Carries All the Weight. CEO Aaron Schapper said resin costs have "since declined and stabilized from their recent peak" while pricing actions "remain in place."

Management expects significant sequential margin improvement in Q4. That pledge is the entire bull case — and it's unproven. The company also quietly downgraded its Vehicle end-market outlook, representing about 13% of sales, from stable to declining.

• The Valuation Offers Little Cushion. Myers used the sale of its North American tire-supply business to cut net debt by $28.5 million, lowering its debt-to-earnings ratio to 1.86 times. That's encouraging. But at roughly 15.5× forward earnings, the stock still trades above its five-year average — and those estimates are likely headed lower.

Year-to-date free cash flow of $61.9 million is up 29% , providing real support, yet investors must decide whether one quarter of margin recovery can justify a multiple built for steady improvement.

The bottom line: Myers proved it can sell more; it has not yet proved it can keep more. Until Q4 confirms the rebound, the stock trades on faith, not facts.